Literature DB >> 25624083

The harm of prophylactic octreotide in pancreatoduodenectomy: more artefact than fact?

Xihua Yang1, Shirali Patel, Steven C Cunningham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25624083      PMCID： PMC4368404          DOI： 10.1111/hpb.12382

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  6 in total

1.  Intravenous and subcutaneous administration of a long-acting somatostatin analogue: effects on glucose metabolism and splanchnic haemodynamics in healthy subjects.

Authors:  L S Eriksson; J Wahren
Journal:  Eur J Clin Invest       Date:  1989-04       Impact factor: 4.686

2.  Prophylactic octreotide for pancreatoduodenectomy: more harm than good?

Authors:  Matthew T McMillan; John D Christein; Mark P Callery; Stephen W Behrman; Jeffrey A Drebin; Tara S Kent; Benjamin C Miller; Russell S Lewis; Charles M Vollmer
Journal:  HPB (Oxford)       Date:  2014-07-10       Impact factor: 3.647

3.  Long-term haemodynamic effects of octreotide on postprandial splanchnic hyperemia in humans: a placebo-controlled echo-doppler study.

Authors:  D Ludwig; S Terai; A Brüning; E F Stange
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

4.  Effect of somatostatin on regional splanchnic blood flows in man. Angiographic studies.

Authors:  H Samnegård; G Tydén; L Thulin; L Friman; R Udén
Journal:  Acta Chir Scand Suppl       Date:  1980

Review 5.  Somatostatin analogues for pancreatic surgery.

Authors:  Kurinchi Selvan Gurusamy; Rahul Koti; Giuseppe Fusai; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

6.  Fluctuations in the secretion of pancreatic enzymes between consecutive doses of octreotide: implications for the management of fistulae.

Authors:  S A Jenkins; D M Nott; J N Baxter
Journal:  Eur J Gastroenterol Hepatol       Date:  1995-03       Impact factor: 2.566
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.